Detail
| LncRNA Name | XLOC_039890 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | RNA-seq, qPCR etc. |
| Sample | CRC tissues, cell lines (HCT116, HT29, SW480, SW620, RKO, DLD1, LOVO, DKO, LS180, CaCO2) |
| Expression Pattern | down-regulated |
| Function Description | Lnc-64 (XLOC_039890) was highly expressed in DKO cells, but the expression was lost in HCT116, HT29, SW480, SW620, RKO, DLD1, LOVO, LS180 and CaCO2 cells. The expression was reduced in 81.3% (13/16) of primary colorectal cancer, but it was highly expressed in normal colorectal mucosa. |
| Pubmed ID | 27115166 |
| Year | 2016 |
| Title | Systematic study of novel lncRNAs in different gastrointestinal cancer cells. |
| External Links |
| Links for XLOC_039890 | GenBank HGNC lncrnadb Noncode |
| Links for colorectal cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.